Upcoming webinar

DREAMing beyond stage IVA: Lung transplantation and molecular surveillance for lung-confined NSCLC

Date: Thursday, September 10, 2026

Time: 2:30 PM CT (60-minute webinar)

Registrants will receive a recording of the webinar approximately one week after the event.

Overview:

Join the Northwestern Lung Transplant team behind the groundbreaking DREAM Study as they share findings from its recent JAMA publication, "Lung Transplant for Refractory Lung-Limited Stage IV Non-Small Cell Lung Cancer."

A new frontier: Transplant as a viable option for patients with primary lung stage IVA cancer—offering a path forward to those who previously had no alternatives. Balancing the risk of recurrence and rejection is complicated for these patients. Particularly because recurrence is a major concern with a 40-50% chance of recurrence after double lung transplant of stage IVA NSCLC.

Innovation that makes it possible: With the combined power of Signatera™ and Prospera™, these patients benefit from molecular detection of recurrence with ongoing rejection surveillance to ensure the right balance of immunosuppression.

Natera Honey Pot

Register Now:

First Name*

Last Name*

Email Address*

Job Title*

Phone*

Company Name*

Postal Code*

Country*

I am a*

Do you have any questions for the presenters that you would like to submit before the webinar?

Please fill in the field above only if you have specific questions. Otherwise, leave it blank.

Natera would like to send you information about our products and services. You may unsubscribe from these communications at any time.

Hear from our speakers:

Ambalavanan Arunachalam, MD

Medical Director, Lung Transplant

Northwestern Memorial Hospital

Ankit Bharat, MD, FACS

Chief, Division of Thoracic Surgery

Northwestern Memorial Hospital

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the tests. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2026 Natera, Inc. All Rights Reserved.

13011 McCallen Pass, Building A Suite 100 | Austin, TX 78753 | natera.com | Do Not Share My Personal Information | Privacy Policy